Identification of the mechanisms of malignant progression of triple-negative breast cancer via epigenetic changes

被引:0
|
作者
Ogikubo, Kazuki [1 ]
Nishida, Jun [2 ,3 ]
Takahashi, Kei [2 ,4 ]
Morikawa, Masato [2 ,5 ]
Ehata, Shogo [2 ,6 ]
Koinuma, Daizo [2 ]
Miyazono, Kohei [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Appl Pathol, Tokyo, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo, Japan
[3] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
[4] Univ Alberta, Dept Chem, Edmonton, AB, Canada
[5] Teikyo Univ, Adv Comprehens Res Org, Tokyo, Japan
[6] Wakayama Med Univ, Sch Med, Dept Path, Wakayama, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-3240
引用
收藏
页码:1949 / 1949
页数:1
相关论文
共 50 条
  • [41] Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer
    Zheng, Yiwen
    Li, Shujin
    Tang, Hongchao
    Meng, Xuli
    Zheng, Qinghui
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [42] ETS1 is a prognostic biomarker of triple-negative breast cancer and promotes the triple-negative breast cancer progression through the YAP signaling
    Li, Yanlin
    Wu, Tiantian
    Peng, Ziluo
    Tian, Xianyan
    Dai, Qian
    Chen, Miao
    Zhu, Jun
    Xia, Song
    Sun, Aiqin
    Yang, Wannian
    Lin, Qiong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (11): : 5074 - 5084
  • [43] DLAT promotes triple-negative breast cancer progression via YAP1 activation
    Liu, Diya
    Wang, Xuehui
    Qian, Fengyuan
    Ye, Danrong
    Deng, Xiaochong
    Fang, Lin
    CANCER BIOLOGY & THERAPY, 2024, 25 (01)
  • [44] Identification of Cancer-Specific Glycoproteins in Triple-Negative Breast Cancer
    Tseng, L. H.
    Argani, P.
    Li, Y.
    Tian, Y.
    Lopez, M. F.
    Sarracino, D.
    Rezai, T.
    Athanas, M.
    Krastins, B.
    Chan, D. W.
    Zhang, H.
    MODERN PATHOLOGY, 2009, 22 : 72A - 72A
  • [45] Identification of Interacting Stromal Axes in Triple-Negative Breast Cancer
    Saleh, Sadiq M. I.
    Bertos, Nicholas
    Gruosso, Tina
    Gigoux, Mathieu
    Souleimanova, Margarita
    Zhao, Hong
    Omeroglu, Atilla
    Hallett, Michael T.
    Park, Morag
    CANCER RESEARCH, 2017, 77 (17) : 4673 - 4683
  • [46] Identification of Cancer-Specific Glycoproteins in Triple-Negative Breast Cancer
    Tseng, L. H.
    Argani, P.
    Li, Y.
    Tian, Y.
    Lopez, M. F.
    Sarracino, D.
    Rezai, T.
    Athanas, M.
    Krastins, B.
    Chan, D. W.
    Zhang, H.
    LABORATORY INVESTIGATION, 2009, 89 : 72A - 72A
  • [47] Antitumor Effect of Demethylzeylasteral (T-96) on Triple-Negative Breast Cancer via LSD1-Mediate Epigenetic Mechanisms
    Shen, Zhengjie
    Gu, Yongjuan
    Jiang, Ruiyang
    Qian, Heya
    Li, Siyuan
    Xu, Lixian
    Gu, Wenzhe
    Zuo, Yun
    ANALYTICAL CELLULAR PATHOLOGY, 2022, 2022
  • [48] Epigenetics of Triple-Negative Breast Cancer via Natural Compounds
    Kaleem, Mohammed
    Perwaiz, Maryam
    Nur, Suza Mohammad
    Abdulrahman, Abdulrasheed O.
    Ahmad, Wasim
    Al-Abbasi, Fahad A.
    Kumar, Vikas
    Kamal, Mohammad Amjad
    Anwar, Firoz
    CURRENT MEDICINAL CHEMISTRY, 2022, 29 (08) : 1436 - 1458
  • [49] Regulatory gene linked to progression and relapse of triple-negative breast cancer
    Brown, Emily
    PHARMACOGENOMICS, 2014, 15 (06) : 733 - 733
  • [50] Correlation between the Warburg effect and progression of triple-negative breast cancer
    Liu, Shaojun
    Li, Yuxuan
    Yuan, Meng
    Song, Qing
    Liu, Min
    FRONTIERS IN ONCOLOGY, 2023, 12